Quyu Jiedu Prescription for postoperative maintenance treatment of metastatic colorectal cancer : a prospective, single center, randomized, controlled clinical study
- Conditions
- colorectal cancer
- Registration Number
- ITMCTR2100005331
- Lead Sponsor
- Zhongshan Affiliated Hospital Guangzhou University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Male or female aged 18 years to 80 years old;
2. Pathologically diagnosed as colorectal adenocarcinoma;
3. At the time of initial diagnosis, enhanced CT or MRI showed that the clinical stage of colon cancer was stage IV with liver and / or lung metastasis, and R0 resection or radiofrequency ablation was performed on the primary tumor and metastatic lesions. The perioperative chemotherapy was completed, and the CT or MRI examination reached NED(No evidence of disease) within 4 weeks before enrollment.
4. ECOG PS 0-1
5. There were no other underlying diseases affecting organ function.
6. Understand, be willing to give consent, and sign the written informed consent form (ICF) prior to undergoing any study-specific procedure.
1. Patients diagnosed with more than one malignancy.
2. Pregnant or lactating women.
3. Patients with mental illness
4. Combined with coronary heart disease, myocardial infarction, renal failure, pulmonary embolism and other diseases that may affect the survival of patients
5. Patients with poor compliance can not cooperate with the treatment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PFS;
- Secondary Outcome Measures
Name Time Method OS;side effect;